The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions
Open accessAbstract
The hepatic organic anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clinical drug-drug interactions. Predicting potential interactions with OATPs is, therefore, of value. Here, we developed in vitro and in silico models for identification and prediction of specific and general inhibitors of OATP1B1, OATP1B3, and OATP2B1. The maximal transport activity (MTA) of each OATP in human liver was predicted from transport kinetics and protein quantification. We then used MTA to predict the effects of a subset of inhibitors on atorvastatin uptake in vivo. Using a data set of 225 drug-like compounds, 91 OATP inhibitors were identified. In silico models indicated that lipophilicity and polar surface area are key molecular features of OATP inhibition. MTA predictions identified OATP1B1 and OATP1B3 as major determinants of atorvastatin uptake in vivo. The relative contributions to overall hepatic uptake varied with isoform specificities of the inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Universal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
Self-citationMembrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
Schachter, M. (2005) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00299.x · Cited by 1,211
Copeland, R. A. (2005) · PubMed · Cited by 1,092
Impact of OATP transporters on pharmacokinetics
Kalliokoski, A., & Niemi, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00430.x · Cited by 995
The superfamily of organic anion transporting polypeptides
Hagenbuch, B., & Meier, P. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00633-8 · Cited by 861
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 723
A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)
Hsiang, B., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V., Yang, W.-P., & Kirchgessner, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37161 · Cited by 641
Niemi, M., Pasanen, M. K., & Neuvonen, P. J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002857 · Cited by 633
Tirona, R. G., Leake, B. F., Merino, G., & Kim, R. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103792200 · Cited by 626
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g156 · Cited by 620
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
Cvetkovic, M., Leake, B., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 597
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Self-citationWiśniewski, J. R., Zougman, A., & Mann, M. (2009) · Journal of Proteome Research · doi:10.1021/pr900748n · Cited by 545
Self-citationIdentification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1
Abe, T., Kakyo, M., Tokui, T., Nakagomi, R., Nishio, T., Nakai, D., Nomura, H., Unno, M., Suzuki, M., Naitoh, T., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17159 · Cited by 543
Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001448200 · Cited by 522
Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6
Cui, Y., König, J., Leier, I., Buchholz, U., & Keppler, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004968200 · Cited by 515
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068056 · Cited by 443
Ohtsuki, S., Schaefer, O., Kawakami, H., Inoue, T., Liehner, S., Saito, A., Ishiguro, N., Kishimoto, W., Ludwig-Schwellinger, E., Ebner, T., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042259 · Cited by 434
A widely applicable set of descriptors
Labute, P. (2000) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(00)00068-1 · Cited by 429
Kullak-Ublick, G. A., Hagenbuch, B., Stieger, B., Schteingart, C. D., Hofmann, A. F., Wolkoff, A. W., & Meier, P. J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90588-x · Cited by 428
Identification and Characterization of a Prostaglandin Transporter
Kanai, N., Lu, R., Satriano, J. A., Bao, Y., Wolkoff, A. W., & Schuster, V. L. (1995) · Science · doi:10.1126/science.7754369 · Cited by 411
Transporter Pharmacogenetics and Statin Toxicity
Niemi, M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.197 · Cited by 330
Lau, Y. Y., Huang, Y., Frassetto, L., & Benet, L. Z. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100038 · Cited by 327
Tirona, R. G., Leake, B. F., Wolkoff, A. W., & Kim, R. B. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043026 · Cited by 324
Pizzagalli, F., Hagenbuch, B., Stieger, B., Klenk, U., Folkers, G., & Meier, P. J. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0309 · Cited by 320
Matsson, P., Pedersen, J. M., Norinder, U., Bergström, C. A. S., & Artursson, P. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9896-0 · Cited by 316
Self-citationShi, Z., Peng, X.-X., Kim, I.-W., Shukla, S., Si, Q.-S., Robey, R. W., Bates, S. E., Shen, T., Ashby, C. R., Fu, L.-W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2686 · Cited by 315
Transporters involved in the hepatic uptake of 99mTc-mebrofenin and indocyanine green
de Graaf, W., Häusler, S., Heger, M., van Ginhoven, T. M., van Cappellen, G., Bennink, R. J., Kullak-Ublick, G. A., Hesselmann, R., van Gulik, T. M., & Stieger, B. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.047 · Cited by 304
Noé, J., Portmann, R., Brun, M.-E., & Funk, C. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012930 · Cited by 291
Hepatic Transport of Bile Salts
KULLAK-UBLICK, G. A., STIEGER, B., HAGENBUCH, B., & MEIER, P. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9426 · Cited by 291
Kodaira, H., Kusuhara, H., Ushiki, J., Fuse, E., & Sugiyama, Y. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162321 · Cited by 266
MDR- and CYP3A4-mediated drug–herbal interactions
Pal, D., & Mitra, A. K. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.010 · Cited by 254
Jacobson, T. A. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.080 · Cited by 243
Sasaki, M., Suzuki, H., Ito, K., Abe, T., & Sugiyama, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109081200 · Cited by 228
The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters
Kis, O., Robillard, K., Chan, G. N. Y., & Bendayan, R. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.001 · Cited by 226
Fruit juice inhibition of uptake transport: a new type of food–drug interaction
Bailey, D. G. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03722.x · Cited by 222
Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors
Proctor, N. J., Tucker, G. T., & Rostami-Hodjegan, A. (2004) · Xenobiotica · doi:10.1080/00498250310001646353 · Cited by 219
GRUBE, M., KOCK, K., OSWALD, S., DRABER, K., MEISSNER, K., ECKEL, L., BOHM, M., FELIX, S., VOGELGESANG, S., & JEDLITSCHKY, G. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.010 · Cited by 215
Tamai, I., Nozawa, T., Koshida, M., Nezu, J.-I., Sai, Y., & Tsuji, A. (2001) · Pharmaceutical Research · doi:10.1023/a:1013077609227 · Cited by 211
Marchetti, S., de Vries, N. A., Buckle, T., Bolijn, M. J., van Eijndhoven, M. A. J., Beijnen, J. H., Mazzanti, R., van Tellingen, O., & Schellens, J. H. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2250 · Cited by 201
Zelcer, N., Huisman, M. T., Reid, G., Wielinga, P., Breedveld, P., Kuil, A., Knipscheer, P., Schellens, J. H. M., Schinkel, A. H., & Borst, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303504200 · Cited by 200
Minematsu, T., & Giacomini, K. M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0731 · Cited by 196
Ahlin, G., Karlsson, J., Pedersen, J. M., Gustavsson, L., Larsson, R., Matsson, P., Norinder, U., Bergström, C. A. S., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003152 · Cited by 190
Self-citationMatsushima, S., Maeda, K., Kondo, C., Hirano, M., Sasaki, M., Suzuki, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085589 · Cited by 190
Expression, transport properties, and chromosomal location of organic anion transporter subtype 3
Walters, H. C., Craddock, A. L., Fusegawa, H., Willingham, M. C., & Dawson, P. A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.6.g1188 · Cited by 180
Wiśniewski, J. R., Zielinska, D. F., & Mann, M. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2010.12.004 · Cited by 175
Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3
Gui, C., Miao, Y., Thompson, L., Wahlgren, B., Mock, M., Stieger, B., & Hagenbuch, B. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.042 · Cited by 174
Sai, Y., Kaneko, Y., Ito, S., Mitsuoka, K., Kato, Y., Tamai, I., Artursson, P., & Tsuji, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009530 · Cited by 168
Self-citationZaher, H., Khan, A. A., Palandra, J., Brayman, T. G., Yu, L., & Ware, J. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050113v · Cited by 162
Smith, N. F., Marsh, S., Scott-Horton, T. J., Hamada, A., Mielke, S., Mross, K., Figg, W. D., Verweij, J., McLeod, H. L., & Sparreboom, A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100011 · Cited by 162
Proteomic Mapping of Brain Plasma Membrane Proteins
Nielsen, P. A., Olsen, J. V., Podtelejnikov, A. V., Andersen, J. R., Mann, M., & Wiśniewski, J. R. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500002-mcp200 · Cited by 161
Ismair, M. G., Stieger, B., Cattori, V., Hagenbuch, B., Fried, M., Meier, P. J., & Kullak-Ublick, G. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.28704 · Cited by 156
Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
Bossuyt, X., Müller, M. M., Hagenbuch, B., & Meier, P. J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12411-7 · Cited by 153
Wang, X., Wolkoff, A. W., & Morris, M. E. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005926 · Cited by 148
Ahlin, G., Hilgendorf, C., Karlsson, J. E., Szigyarto, C. A., Uhlén, M., & Artursson, P. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028654 · Cited by 142
Self-citationUrquhart, B. L., Ware, J. A., Tirona, R. G., Ho, R. H., Leake, B. F., Schwarz, U. I., Zaher, H., Palandra, J., Gregor, J. C., Dresser, G. K., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f974dc · Cited by 141
Pedersen, J. M., Matsson, P., Bergström, C. A. S., Norinder, U., Hoogstraate, J. A., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015683 · Cited by 131
Self-citationLins, R. L., Matthys, K. E., Verpooten, G. A., Peeters, P. C., Dratwa, M., Stolear, J.-C., & Lameire, N. H. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg048 · Cited by 128
Karlgren, M., Ahlin, G., Bergström, C. A. S., Svensson, R., Palm, J. E., & Artursson, P. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0564-9 · Cited by 118
Self-citationModification of OATP2B1-Mediated Transport by Steroid Hormones
Grube, M., Köck, K., Karner, S., Reuther, S., Ritter, C. A., Jedlitschky, G., & Kroemer, H. K. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026450 · Cited by 109
Gui, C., Obaidat, A., Chaguturu, R., & Hagenbuch, B. (2010) · Current Chemical Genomics · doi:10.2174/1875397301004010001 · Cited by 107
Pharmacogenomic biomarkers: new tools in current and future drug therapy
Sim, S. C., & Ingelman‐Sundberg, M. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.008 · Cited by 106
Kindla, J., Müller, F., Mieth, M., Fromm, M. F., & König, J. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037622 · Cited by 106
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
Kuang, Y., Shen, T., Chen, X. '., Sodani, K. S., Hopper-Borge, E. A., Tiwari, A. K., Lee, J. W. K. K., Fu, L., & Chen, Z. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.021 · Cited by 100
Schwarz, U. I., zu Schwabedissen, H. E. M., Tirona, R. G., Suzuki, A., Leake, B. F., Mokrab, Y., Mizuguchi, K., Ho, R. H., & Kim, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328342f5b1 · Cited by 90
Chang, C. K., Pang, K. S., Swaan, P. W., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082370 · Cited by 88
Yamaguchi, H., Kobayashi, M., Okada, M., Takeuchi, T., Unno, M., Abe, T., Goto, J., Hishinuma, T., & Mano, N. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.10.040 · Cited by 76
Dynamic localization of hepatocellular transporters in health and disease
Roma, M. G., Crocenzi, F. A., & Mottino, A. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6786 · Cited by 68
Fenner, K. S., Jones, H. M., Ullah, M., Kempshall, S., Dickins, M., Lai, Y., Morgan, P., & Barton, H. A. (2011) · Xenobiotica · doi:10.3109/00498254.2011.626464 · Cited by 56
Self-citationWestholm, D. E., Stenehjem, D. D., Rumbley, J. N., Drewes, L. R., & Anderson, G. W. (2009) · Endocrinology · doi:10.1210/en.2008-0188 · Cited by 53
Chen, Z. (2009) · Oncology Reports · doi:10.3892/or_00000248 · Cited by 53
Oostendorp, R. L., van de Steeg, E., van der Kruijssen, C. M. M., Beijnen, J. H., Kenworthy, K. E., Schinkel, A. H., & Schellens, J. H. M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024901 · Cited by 49
Thyroid hormone transporters in the brain
Suzuki, T., & Abe, T. (2008) · The Cerebellum · doi:10.1007/s12311-008-0029-9 · Cited by 39
Screening of OATP1B1/3 and OCT1 inhibitors in cryopreserved hepatocytes in suspension
Badolo, L., Rasmussen, L. M., Hansen, H. R., & Sveigaard, C. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.023 · Cited by 37
Distribution of Rat Organic Anion Transporting Polypeptide-E (oatp-E) in the Rat Eye
Ito, A., Yamaguchi, K., Tomita, H., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1108 · Cited by 36
An evolutionarily ancient Oatp: insights into conserved functional domains of these proteins
Cai, S., Wang, W., Soroka, C. J., Ballatori, N., & Boyer, J. L. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00458.2001 · Cited by 32
Gui, C., & Hagenbuch, B. (2010) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2010.01.005 · Cited by 31
Cited by
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
Ling, Y., Hao, Z.-Y., Liang, D., Zhang, C.-L., Liu, Y.-F., & Wang, Y. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s329547 · Cited by 414
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Chu, X., Bleasby, K., & Evers, R. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.741589 · Cited by 306
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Self-citationWiśniewski, J. R., Vildhede, A., Norén, A., & Artursson, P. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.01.016 · Cited by 185
Self-citation
Metadata
- Authors
- Karlgren, M., Vildhede, A., Norinder, U., Wisniewski, J. R., Kimoto, E., Lai, Y., Haglund, U., & Artursson, P.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-05-15
- Volume
- 55
- Issue
- 10
- Pages
- 4740-4763
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2044459219
- Cited by
- 369
- References
- 79
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.